What Is Antitrust Due Diligence and Why It Protects M&A Deals

The review tests whether combining two businesses will reduce competition enough to draw a government challenge or a private lawsuit. Its findings shape valuation, indemnities, and how the parties allocate regulatory risk. A clean analysis becomes a negotiating asset rather than a formality.

Any transaction that meaningfully increases market concentration warrants review, and large deals trigger a mandatory federal filing. Smaller deals still merit analysis when the parties compete directly or one is an emerging rival. Competitive overlap drives the need for review, not deal size alone.

Deal attorneys usually lead the analysis, working with economists and the client's commercial team to gather market data. Buyers carry the heaviest burden because they inherit the combined entity's exposure. Sellers benefit from a parallel review that avoids surprises capable of delaying closing.

The Sherman Act reaches restraints of trade and monopolization, while the Clayton Act supplies the merger standard by prohibiting deals that may substantially lessen competition. Section 4 of the Clayton Act lets private plaintiffs recover treble damages for antitrust violations. Together these statutes define both the transaction test and the litigation risk.

Courts condemn a narrow set of conduct, such as price-fixing and bid-rigging among competitors, as per se illegal without weighing its effects. Most other arrangements, including many vertical agreements, fall under the rule of reason, which balances procompetitive benefits against harm. Knowing which framework applies tells the parties how much a given practice actually risks.

The Federal Trade Commission and the Department of Justice Antitrust Division share federal merger review under overlapping jurisdiction, and the industry usually determines which one takes a given deal. Both evaluate transactions under the 2023 Merger Guidelines, which the agencies issued in December 2023 and confirmed would remain in effect in 2025. Both also apply the Clayton Act standard.

New York's Donnelly Act, codified at General Business Law Section 340, addresses restraints of trade and monopolies under state law and allows treble damages of its own. The New York Attorney General can investigate deals with strong in-state effects, so a transaction that clears federal review can still draw state scrutiny. Cross-border deals may also require clearance abroad, which makes coordinating these tracks essential.

Defining the relevant product and geographic market frames every later conclusion, because a narrow market raises measured concentration. Analysts often gauge that concentration with the Herfindahl-Hirschman Index and test how customers substitute among competing offerings. The chosen definition frequently decides the outcome.

Horizontal mergers between direct competitors draw the sharpest scrutiny because they remove a rival outright. Vertical deals between suppliers and customers raise foreclosure concerns instead. Each theory demands different evidence.

Reliance on a few customers or suppliers signals leverage that enforcers examine closely. Reviewers map these relationships to find bottlenecks the combined firm could exploit. Concentrated inputs often carry the most risk.

Internal pricing records and any history of contact with competitors can surface coordination concerns. Enforcers read these documents for evidence of intent to reduce rivalry. Clean pricing practices strengthen the parties' position.

For 2026, transactions valued above $133.9 million generally require premerger notification to the FTC and DOJ under Section 7A of the Clayton Act. An expanded HSR filing form now demands far more detail on deal rationale and competitive overlaps, so preparation takes longer than it once did. Confirm the current thresholds and form requirements before filing, because they change.

The initial waiting period runs 30 days, and most deals clear once it ends. A second request for documents adds another waiting period and can extend review by months while the parties produce records. Building this into the closing calendar prevents avoidable delay.

Until the waiting period ends, the parties must keep operating as independent competitors. Coordinating prices, allocating customers, or exchanging competitively sensitive information during diligence can expose both sides to gun-jumping liability. Clean teams and disciplined information protocols keep the review on track.

Agencies sometimes approve a deal only if the parties agree to conditions that address specific harms. The parties negotiate these commitments before clearance rather than accepting them afterward. Anticipating them early preserves deal value.

Map the antitrust workstream against the closing schedule from day one, including time for a possible second request. A realistic calendar keeps the analysis from becoming a bottleneck. Front-loading the work pays off.

Formalize competitive analysis, board discussions, and customer feedback into the record before closing. Contemporaneous documents carry more weight than explanations offered after an inquiry begins. Preserve the communications that support a procompetitive rationale.

Bringing specialized attorneys in early lets them shape structure rather than react to problems. They coordinate economists, filings, and remedy strategy across jurisdictions. Their involvement matters most before the parties lock in terms.